Title
Agency and Joint Attention,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Human infants do not seem to be born with concepts of self or joint attention. One basic goal of Agency and Joint Attention is to unravel how these abilities originate. One approach that has received a lot of recent attention is social. Some argue that by virtue of an infant's intense eye gaze with her mother, she is able, by the age of four months, to establish a relationship with her mother that differentiates between "me" and "you." At about twelve months, the infant acquires the nonverbal ability to share attention with her mother or other caregivers. Although the concepts of self and joint attention are nonverbal and uniquely human, the question remains, how do we establish metacognitive control of these abilities? A tangential question is whether nonhuman animals develop abilities that are analogous to self and joint attention.Much of this volume is devoted to the development of metacognition of self and joint attention in experiments on the origin of consciousness, knowing oneself, social referencing, joint action, the neurological basis of joint attention, the role of joint action, mirror neurons, phenomenology, and cues for agency.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.